These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 28427077
1. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer. Liang HB, Cao Y, Ma Q, Shu YJ, Wang Z, Zhang F, Ye YY, Li HF, Xiang SS, Song XL, Xu Y, Zhang YC, Bao RF, Yuan RY, Zhang YJ, Hu YP, Jiang L, Li ML, Wang XA, Wu XS, Wu WG, Zhao S, Fand Y, Cui XP, Lu YS, Zhou J, Zheng L, Gong W, Liu YB. Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077 [Abstract] [Full Text] [Related]
2. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway. Shu YJ, Weng H, Ye YY, Hu YP, Bao RF, Cao Y, Wang XA, Zhang F, Xiang SS, Li HF, Wu XS, Li ML, Jiang L, Lu W, Han BS, Jie ZG, Liu YB. Mol Cancer; 2015 Jan 27; 14(1):12. PubMed ID: 25623055 [Abstract] [Full Text] [Related]
3. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer. Cao Y, Liang H, Zhang F, Luan Z, Zhao S, Wang XA, Liu S, Bao R, Shu Y, Ma Q, Zhu J, Liu Y. J Exp Clin Cancer Res; 2016 Apr 16; 35():68. PubMed ID: 27084680 [Abstract] [Full Text] [Related]
4. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo. Qin Y, Zhou Y, Ge A, Chang L, Shi H, Fu Y, Luo Q. Biomed Pharmacother; 2019 Oct 16; 118():109266. PubMed ID: 31401397 [Abstract] [Full Text] [Related]
5. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling. Qin Y, Meng L, Fu Y, Quan Z, Ma M, Weng M, Zhang Z, Gao C, Shi X, Han K. Oncotarget; 2017 Mar 21; 8(12):19980-19996. PubMed ID: 28212545 [Abstract] [Full Text] [Related]
6. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway. Shen H, He M, Lin R, Zhan M, Xu S, Huang X, Xu C, Chen W, Yao Y, Mohan M, Wang J. J Exp Clin Cancer Res; 2019 Jun 10; 38(1):247. PubMed ID: 31182136 [Abstract] [Full Text] [Related]
7. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer. He M, Zhan M, Chen W, Xu S, Long M, Shen H, Shi Y, Liu Q, Mohan M, Wang J. Cell Physiol Biochem; 2017 Jun 10; 42(5):2078-2092. PubMed ID: 28803245 [Abstract] [Full Text] [Related]
8. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer]. Yang M, Zhu X, Shen Y, He Q, Qin Y, Shao Y, Yuan L, Ye H. Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug 20; 42(8):1109-1118. PubMed ID: 36073208 [Abstract] [Full Text] [Related]
9. Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma. Letelier P, Garcia P, Leal P, Ili C, Buchegger K, Riquelme I, Sandoval A, Tapia O, Roa JC. Appl Immunohistochem Mol Morphol; 2014 Aug 20; 22(7):530-6. PubMed ID: 24185122 [Abstract] [Full Text] [Related]
10. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway. Pan MS, Wang H, Ansari KH, Li XP, Sun W, Fan YZ. J Exp Clin Cancer Res; 2020 Nov 05; 39(1):234. PubMed ID: 33153467 [Abstract] [Full Text] [Related]
11. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR. Zhao S, Cao Y, Liu SB, Wang XA, Bao RF, Shu YJ, Hu YP, Zhang YJ, Jiang L, Zhang F, Liang HB, Li HF, Ma Q, Xu Y, Wang Z, Zhang YC, Chen L, Zhou J, Liu YB. J Exp Clin Cancer Res; 2016 Jun 18; 35(1):97. PubMed ID: 27317099 [Abstract] [Full Text] [Related]
12. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway. Liu ZY, Cao J, Zhang JT, Xu GL, Li XP, Wang FT, Ansari KH, Mohamed H, Fan YZ. Oncotarget; 2017 Jul 25; 8(30):49897-49914. PubMed ID: 28611292 [Abstract] [Full Text] [Related]
13. Ponicidin inhibited gallbladder cancer proliferation and metastasis by decreasing MAGEB2 expression through FOXO4. Zhao C, Zhang J, Yang ZY, Shi LQ, Liu SL, Pan LJ, Dong P, Zhang Y, Xiang SS, Shu YJ, Mei JW. Phytomedicine; 2023 Jun 25; 114():154785. PubMed ID: 37002972 [Abstract] [Full Text] [Related]
14. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1. Lu W, Hu Y, Ma Q, Zhou L, Jiang L, Li Z, Zhao S, Xu Y, Shi W, Li S, Liu Y. Oncotarget; 2016 Sep 20; 7(38):62364-62376. PubMed ID: 27577078 [Abstract] [Full Text] [Related]
15. Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma. Yu R, Li C, Lin X, Chen Q, Li J, Song L, Lin L, Liu J, Zhang Y, Kong W, Ouyang X, Chen X. Pathol Res Pract; 2017 Aug 20; 213(8):964-968. PubMed ID: 28559119 [Abstract] [Full Text] [Related]
16. Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer. Liu B, Shen ED, Liao MM, Hu YB, Wu K, Yang P, Zhou L, Chen WD. Tumour Biol; 2016 Jul 20; 37(7):9875-86. PubMed ID: 26812694 [Abstract] [Full Text] [Related]
19. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway. Yang L, Gao Q, Wu X, Feng F, Xu K. J Exp Clin Cancer Res; 2018 Aug 07; 37(1):186. PubMed ID: 30086773 [Abstract] [Full Text] [Related]